Literature DB >> 1602599

Changes in oxygen uptake-work rate relationship as a compensatory mechanism in patients with heart failure.

H Itoh1, M Nakamura, C Ikeda, E Yanagisawa, F Hatogai, M Iwadare, K Taniguchi.   

Abstract

To assess the compensatory change in oxygen uptake (VO2) kinetics during exercise in patients with heart failure, we performed cardiopulmonary exercise testing using a cycle ergometer in 29 cardiac patients and 18 normal subjects. The work rate increased linearly (1w/6sec) after a 4 min, 20w warm-up. The ratio of increase in VO2 to increase in work rate (delta VO2/delta WR) was determined by linear regression of VO2 plots. Cardiac output by dye dilution method and plasma norepinephrine concentration (NE) were measured at rest and 20w warm-up. VO2 at rest and at 20w warm-up and delta VO2/delta WR decreased significantly with increasing severity in NYHA functional classification. delta VO2/delta WR showed significant negative correlation to the difference in NE levels at rest and at 20w (r = -0.69, p less than 0.001). The delta values of arteriovenous O2 content difference, calculated using Fick's principle, and cardiac index from rest to 20w warm-up failed to show significant relationship to delta VO2/delta WR. These results suggest that the decrease in VO2 requirement in heart failure patients is due probably to blood redistribution during exercise as a compensatory mechanism for exercise intolerance.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1602599     DOI: 10.1253/jcj.56.504

Source DB:  PubMed          Journal:  Jpn Circ J        ISSN: 0047-1828


  2 in total

Review 1.  Exercise programmes for patients with chronic heart failure.

Authors:  Tim Meyer; Michael Kindermann; Wilfried Kindermann
Journal:  Sports Med       Date:  2004       Impact factor: 11.136

2.  Reduced oxygen uptake increase to work rate increment (DeltaVO2/DeltaWR) is predictable by VO2 response to constant work rate exercise in patients with chronic heart failure.

Authors:  Mamoru Toyofuku; Hiroshi Takaki; Masaru Sugimachi; Toru Kawada; Yoichi Goto; Kenji Sunagawa
Journal:  Eur J Appl Physiol       Date:  2003-06-13       Impact factor: 3.078

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.